Diabetes and its management

In the past decade there has been a rapid expansion in the number of drugs available to treat Diabetes. Different classes of antidiabetic drugs are available with each having different pharmacological mechanism of action. This review presents the commercially available drugs for management of diabetes. Role of various antidiabetic drugs and their side effects are discussed.

• Publication year

  2014

• Venue

  IOSR Journal of Environmental Science, Toxicology and Food Technology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.9790/2402-08545155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1.

  2006cited by this paper
• Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.

  2005cited by this paper
• Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double‐blind, placebo‐controlled studies with single oral doses

  2005cited by this paper
• Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study

  2004cited by this paper
• The effects of oral anti‐hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes

  2004cited by this paper
• ABCD position statement on glitazones

  2004cited by this paper
• Contraindications to the use of metformin

  2003cited by this paper
• Insulin pump therapy in the 21st century

  2002cited by this paper
• Alternative delivery routes: inhaled insulin.

  2002cited by this paper
• DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN

  2001cited by this paper
• The blooming of the French lilac.

  2001cited by this paper
• Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group.

  2000cited by this paper
• Percutaneous transhepatic catheterization of the portal vein: A combined CT- and fluoroscopy-guided technique

  1999cited by this paper
• Thiazolidinediones: a new class of antidiabetic drugs

  1999cited by this paper
• Advancing age and insulin resistance: new facts about an ancient history

  1999cited by this paper
• Treatment of type 2 diabetes mellitus.

  1999cited by this paper
• Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes.

  1999cited by this paper
• Glimepiride

  1998cited by this paper
• Insulin and risk of cardiovascular disease: a meta-analysis.

  1998cited by this paper
• Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Pharmacokinetic Considerations of New Insulin Formulations and Routes of Administration

  1997cited by this paper
• Genetic and environmental architecture of the features of the insulin-resistance syndrome.

  1997cited by this paper
• Oral hypoglycaemic agents. When, how and why.

  1997cited by this paper
• Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes

  1996cited by this paper
• Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

  1995cited by this paper
• Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old.

  1995cited by this paper
• Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota.

  1993cited by this paper
• Trends in Use of Oral Hypoglycemic Agents 1964–1986

  1988cited by this paper
• Mechanism of Metformin Action in Non-Insulin-Dependent Diabetes

  1987cited by this paper
• Pathogenesis and Prevention of the Dawn Phenomenon in Diabetic Patients Treated with CSII

  1986cited by this paper
• Islet transplantation in treating diabetes.

  1986cited by this paper
• [Antidiabetic drugs].

  1979cited by this paper
• Insulin-sensitive and insulin-insensitive types of diabetes mellitus.

  1939cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Impaired Insulin-Stimulated Expression of the Glycogen Synthase Gene in Skeletal Muscle of Type 2 Diabetic Patients Is Acquired Rather Than Inhe

  year unknowncited by this paper

• Circulating lipidome underpins gender differences in the pathogenesis of type 2 diabetes

  2025cites this paper
• THE BRITISH JOURNAL OF CLINICAL PRACTICE Experience with Small Intra-muscular Dose Insulin Treatment of Diabetic Coma and Precoma

  2023cites this paper
• The effect of aerobic and resistance training on insulin resistance index (HOMA-IR) and BCL-2/BAX ratio in apoptotic pathway in the heart tissue of male wistar diabetic rats

  2022cites this paper
• Clinical Study on Newly Detected Type II Diabetes Mellitus Patients with Special Reference to Serum Vitamin D Levels and Obesity

  2021cites this paper
• The Effect of Group Counseling Based on Cognitive-behavioral Approach on Self-Care Behaviors and Illness Perception of Middle-aged Women with Diabetes Type 2: A Quasi-experimental Study

  2020cites this paper
• The Protective Effects of Cultured Mesenchymal Stem Cells onto the Surface of Electrospun Poly-L-Lactide Acid Scaffolds Coated with Matricaria Chamomilla L. Oil in Streptozotocin-Induced Diabetic Rabbits

  2019cites this paper
• Insulinotropic and glucose-lowering peptides from phylogenetically ancient fish with potential for therapy of type 2 diabetes

  2019cites this paper
• The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran

  2018cites this paper
• Effect of Pre-Ramadan Education on Dietary Intake and Anthropometry-Comparison Between Two Groups of Diabetic Patients

  2017cites this paper
• A REVIEW ON PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTI DIABETIC MEDICATIONS IN CLINICAL PRACTICE

  2017cites this paper
• A comparison of 25(OH) vitamin D levels in patients with type 2 diabetes on oral hypoglycemic agents and insulin treatment.

  2016cites this paper
• Prognostički čimbenici uspjeha različitih barijatrijskih zahvata

  2015cites this paper
• Принцип міждисциплінарної інтеграції та апріорної мотивації в медицині невідкладних станів

  2015cites this paper
• A systematic review of research into black and ethnic minority patients' views on self‐management of type 2 diabetes

  2015cites this paper
• Management of type 2 diabetes mellitus: Adherence challenges in environments of low socio-economic status

  2014cites this paper
• An Examination Of The Role Of Neurocognitive Functioning In Illness Management Among Adolescents With Type 1 Diabetes

  2013cites this paper
• The Egyptian Society of Chest Diseases and Tuberculosis Egyptian Journal of Chest Diseases and Tuberculosis

  2013cites this paper
• Retinopathy and risk factors in diabetic patients from Al-Madinah Al-Munawarah in the Kingdom of Saudi Arabia

  2012cites this paper
• The Reno-Protective Effects of Coconut Water on the Kidneys of Diabetic Wistar Rats

  2012cites this paper
• Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs

  2012cites this paper
• Catechin, as an Emerging Front-line Defense Flavonoid against Stress-Related Disorders: An Updated Review

  year unknowninfluential citation